febuxostat
febuxostat is listed in the FDA National Drug Code directory with 22 NDC codes, marketed under brand names including FEBUXOSTAT, Febuxostat, ULORIC. Available dosage forms: tablet, tablet, coated, powder.
Drug Details
- Generic Name
- febuxostat
- Brand Names
- FEBUXOSTAT, Febuxostat, ULORIC, febuxostat
- Application Number
- ANDA206266
- Sponsor
- Solco Healthcare US LLC
- NDC Codes
- 22
- Dosage Forms
- TABLET, TABLET, COATED, POWDER
- Routes
- ORAL
- Active Ingredients
- FEBUXOSTAT
Indications and Usage
1 INDICATIONS AND USAGE Febuxostat tablet is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. Febuxostat tablet is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. ( 1 ) Limitations of Use : Febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia. ( 1 ) Limitations of Use : Febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia.